Joyce Teng

Dermatologist, Pediatric dermatologist

Clinical Associate Professor, Dermatology Clinical Associate Professor, Pediatrics

Professional Education

Medical Education: Vanderbilt University School of Medicine (2001) TN

Residency: Vanderbilt University Medical Center (2005) TN

Board Certification: Pediatric Dermatology, American Board of Dermatology (2006)

Fellowship: University of Colorado Health Science Center (2006) CO

Board Certification: Dermatology, American Board of Dermatology (2005)

Internship: Vanderbilt University Medical Center (2002) TN

Postgraduate Fellowship, Memorial Sloan-Kettering Institute, Molecular Immunology (1997)

PhD, Medical College of Wisconsin, Cellular Immunology (1993)

Medical Education: Medical College Of Wisconsin (1993) WI

Honors & Awards

Research Award, Dermatology Foundation (2009, 2012)

Teaching Award, University of Wisconsin-Madison (2012)

Preceptorship Award, American Society of Dermatologic Surgery (2008, 2010)

William Weston Research Award, Society of Pediatric Dermatology (2009)

Mentorship Award, Women's Dermatology Society (2006)

Administrative Appointments

Director of Pediatric Dermatology, University of Wisconsin-Madison (2007 - 2012)

Director of Pediatric Dermatology Fellowship, Stanford University (2012 - Present)

Director of Pediatric Dermatology, Stanford University (2012 - Present)

An open-label study to evaluate sildenafil for the treatment of lymphatic malformations
Danial, C., Tichy, A. L., Tariq, U., Swetman, G. L., Khuu, P., & Lane, A. T. (2014). An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(6), 1050-1057.

Familial Urticaria Pigmentosa: Report of a Family and Review of the Role of KIT Mutations
Fett, N. M., Teng, J., & Longley, B. J. (2013). Familial Urticaria Pigmentosa: Report of a Family and Review of the Role of KIT Mutations. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 35(1), 113-116.

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference.
Northrup, H., Krueger, Da., & International Tuberous Sclerosis Complex Consensus Group. (2013). Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatric Neurology, 49(4).

Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference.
Krueger, Da., Northrup, H., & International Tuberous Sclerosis Complex Consensus Group. (2013). Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatric Neurology, 49(4).

Dermatofibrosarcoma Protuberans in Children: an Update on the Diagnosis and Treatment
Kornik, R. I., Muchard, L. K., & Teng, J. M. (2012). Dermatofibrosarcoma Protuberans in Children: an Update on the Diagnosis and Treatment. PEDIATRIC DERMATOLOGY, 29(6), 707-713.

Effective Topical Combination Therapy for Treatment of Lichen Striatus in Children: A Case Series and Review
Youssef, S. M., & Teng, J. Mc. (2012). Effective Topical Combination Therapy for Treatment of Lichen Striatus in Children: A Case Series and Review. JOURNAL OF DRUGS IN DERMATOLOGY, 11(7), 872-875.

Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise
Chamcheu, J. C., Wood, G. S., Siddiqui, I. A., Syed, D. N., Adhami, V. M., & Mukhtar, H. (2012). Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise. EXPERIMENTAL DERMATOLOGY, 21(7), 481-489.

Treatment of Recalcitrant Excessive Granulation Tissue with Photodynamic Therapy in an Eight-Year-Old Patient with Focal Dermal Hypoplasia Syndrome
Liu, J., Hsu, P. T., Vanderwielen, B. A., & Teng, J. M. (2012). Treatment of Recalcitrant Excessive Granulation Tissue with Photodynamic Therapy in an Eight-Year-Old Patient with Focal Dermal Hypoplasia Syndrome. PEDIATRIC DERMATOLOGY, 29(3), 324-326.

Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., & Thomson, J. A. (2011). Chemically defined conditions for human iPSC derivation and culture. NATURE METHODS, 8(5), 424-U76.

A Case of Sclerodermatous Graft-versus-Host Disease Responsive to Imatinib Therapy
Lazar, J., Poonawalla, T., & Teng, J. Mc. (2011). A Case of Sclerodermatous Graft-versus-Host Disease Responsive to Imatinib Therapy. PEDIATRIC DERMATOLOGY, 28(2), 172-175.

Lipoatrophic Panniculitis Case Report and Review of the Literature
Shen, L. Y., Edmonson, M. B., Williams, G. P., Gottam, C. C., Hinshaw, M. A., & Teng, J. M. (2010). Lipoatrophic Panniculitis Case Report and Review of the Literature. ARCHIVES OF DERMATOLOGY, 146(8), 877-881.

Topical Rapamycin A Novel Approach to Facial Angiofibromas in Tuberous Sclerosis
Haemel, A. K., O'Brian, A. L., & Teng, J. M. (2010). Topical Rapamycin A Novel Approach to Facial Angiofibromas in Tuberous Sclerosis. ARCHIVES OF DERMATOLOGY, 146(7), 715-718.

Rapid Improvement in Digital Ischemia and Acral Contracture in a Collodion Baby Treated With Topical Tazarotene
Liu, R. H., Becker, B., Gunkel, J., & Teng, J. (2010). Rapid Improvement in Digital Ischemia and Acral Contracture in a Collodion Baby Treated With Topical Tazarotene. JOURNAL OF DRUGS IN DERMATOLOGY, 9(6), 713-716.

Mohs Surgical Excision of a Granular Cell Tumor with Plexiform Features on the Arm of a 7-Year-Old Child
Youssef, S. M., Hinshaw, M., Longley, B. J., Snow, S., & Teng, J. Mc. (2010). Mohs Surgical Excision of a Granular Cell Tumor with Plexiform Features on the Arm of a 7-Year-Old Child. DERMATOLOGIC SURGERY, 36(4), 546-550.

Sweet's panniculitis associated with metastatic breast cancer
Teng, J. Mc., Draper, B. K., & Boyd, A. S. (2007). Sweet's panniculitis associated with metastatic breast cancer. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 56(2), S61-S62.

CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail
King, P. D., Sadra, A., Teng, J. Mc., Bell, G. M., & DuPont, B. (1998). CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail. INTERNATIONAL IMMUNOLOGY, 10(7), 1009-1016.

Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK
King, P. D., Sadra, A., Teng, J. Mc., Liu, X. R., Han, A., & DuPont, B. (1997). Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. JOURNAL OF IMMUNOLOGY, 158(2), 580-590.

The Tec family tyrosine kinases BTK and ITK in lymphocyte development and activation
DuPont, B., August, A., Teng, J. Mc., Sadra, A., & King, P. D. (1997). The Tec family tyrosine kinases BTK and ITK in lymphocyte development and activation. MUNKSGAARD.

Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion.
Teng, J. M., King, P. D., Sadra, A., Liu, X., Han, A., & DuPont, B. (1996). Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion. Tissue antigens, 48(4), 255-264.

CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C
Teng, J. Mc., Liu, X. R., Mills, G. B., & DuPont, B. (1996). CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C. JOURNAL OF IMMUNOLOGY, 156(9), 3222-3232.

RESIDUES OUTSIDE OF THE HLA-A2 PEPTIDE-BINDING GROOVE CAN ABROGATE OR ENHANCE RECOGNITION OF INFLUENZA-VIRUS MATRIX PEPTIDE PULSED CELLS BY CYTOTOXIC T-LYMPHOCYTES
Teng, J. Mc., & HOGAN, K. T. (1994). RESIDUES OUTSIDE OF THE HLA-A2 PEPTIDE-BINDING GROOVE CAN ABROGATE OR ENHANCE RECOGNITION OF INFLUENZA-VIRUS MATRIX PEPTIDE PULSED CELLS BY CYTOTOXIC T-LYMPHOCYTES. MOLECULAR IMMUNOLOGY, 31(6), 445-457.

BOTH MAJOR AND MINOR PEPTIDE-BINDING POCKETS IN HLA-A2 INFLUENCE THE PRESENTATION OF INFLUENZA-VIRUS MATRIX PEPTIDE TO CYTOTOXIC T-LYMPHOCYTES
Teng, J. Mc., & HOGAN, K. T. (1994). BOTH MAJOR AND MINOR PEPTIDE-BINDING POCKETS IN HLA-A2 INFLUENCE THE PRESENTATION OF INFLUENZA-VIRUS MATRIX PEPTIDE TO CYTOTOXIC T-LYMPHOCYTES. MOLECULAR IMMUNOLOGY, 31(6), 459-470.